If you have been reading about peptide backbone and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-12-20. Where a claim depends on a specific study, the study is described rather than over-claimed.
Peptides in this class degrade mainly through hydrolysis, oxidation, and aggregation. The lipid modification improves plasma residence time but can also promote self-association in aqueous solution at higher concentrations. Oxidation of methionine and deamidation of asparagine residues are common chemical liabilities that accumulate during storage. Stability studies therefore track purity loss, aggregate formation, and changes in receptor-binding potency over time under defined temperature and humidity conditions.
Solid peptide is generally held as a lyophilised powder at low temperature to slow degradation, with desiccant to limit moisture uptake. Reconstituted solutions are less stable and are usually kept refrigerated and protected from light for short periods. Repeated freeze-thaw cycles are avoided because they encourage aggregation. Laboratory handling includes work in a fume hood or laminar flow cabinet to limit inhalation and contamination. Weighing and transfer steps are performed with antistatic tools to reduce static-driven loss of fine powder.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
| Property | Value | Notes |
|---|---|---|
| Storage temperature (solid) | -20 °C or below | Freezer storage with desiccant |
| Solubility | Soluble in water and aqueous buffer | Careful dissolution needed at higher concentrations |
| Appearance | White to off-white lyophilised powder | Visual inspection for discolouration |
| Primary analytical method | Reversed-phase HPLC with UV detection | Paired with mass spectrometry for identity |
| Common synonyms | Triple-agonist peptide; GLP-1/GIP/glucagon agonist | Naming varies across the literature |
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
Rosemary Kennedy, sister of US president John F. Kennedy, underwent a lobotomy in 1941 that left her incapacitated and institutionalized for the rest of her life. Howard Dully wrote a memoir of his late-life discovery that he had been lobotomized in 1960 at age 12. Josef Hassid, a Polish violinist and composer, was diagnosed with schizophrenia and died at the age of 26 following a lobotomy performed on him in England. Swedish modernist painter Sigrid Hjertén died following a lobotomy in 1948. American playwright Tennessee Williams's older sister Rose received a lobotomy that left her incapacitated for life; the episode is said to have inspired characters and motifs in some of his works. It is often said that when an iron rod was accidentally driven through the head of Phineas Gage in 1848, this constituted an "accidental lobotomy", or that this event somehow inspired the development of surgical lobotomy a century later. According to the only book-length study of Gage, careful inquiry turns up no such link. In 2011, Daniel Nijensohn, an Argentine-born neurosurgeon at Yale, examined X-rays of Eva Perón and concluded that she underwent a lobotomy for the treatment of pain and anxiety in the last months of her life.
In June 2018, Iván Duque, the candidate of the right-wing Democratic Center party, won the presidential election. On 7 August 2018, he was sworn in as the new President of Colombia to succeed Juan Manuel Santos. Colombia's relations with Venezuela have fluctuated due to ideological differences between the two governments. Colombia has offered humanitarian support with food and medicines to mitigate the shortage of supplies in Venezuela. Colombia's Foreign Ministry said that all efforts to resolve Venezuela's crisis should be peaceful. Colombia proposed the idea of the Sustainable Development Goals and a final document was adopted by the United Nations. In February 2019, Venezuelan president Nicolás Maduro cut off diplomatic relations with Colombia after Colombian President Ivan Duque had helped Venezuelan opposition politicians deliver humanitarian aid to their country. Colombia recognized Venezuelan opposition leader Juan Guaidó as the country's legitimate president. In January 2020, Colombia rejected Maduro's proposal that the two countries restore diplomatic relations. Protests started on 28 April 2021 when the government proposed a tax bill that would greatly expand the range of the 19 percent value-added tax. The 2022 presidential election run-off vote ended in a win for former guerrilla Gustavo Petro, who received 50.47% of the vote compared to 47.27% for independent candidate Rodolfo Hernández. The single-term limit for the country's presidency prevented President Iván Duque from seeking re-election.
==== Surfactins ==== As the name implies, surfactins are potent biosurfactants (surfactants produced by bacteria, yeast, or fungi), and they have been shown to reduce the surface tension of water from 72 to 27 mN/m at very low concentrations. Furthermore, surfactins are also able to permeabilize lipid membranes, allowing them to have specific antimicrobial and antiviral activities. Since surfactins are biosurfactants, they have diverse functional properties. These include low toxicity, biodegradability and a higher tolerance towards variation of temperature and pH, making them very interesting for use in a wide range of applications.
=== OXGR1 receptor-dependent bioactions === OXGR1 (also known as GPR99) is a G protein-coupled receptor, i.e., a receptor located on the surface membrane of cells that binds certain ligands and is thereby stimulated to activate G proteins that elicit pre-programmed responses in their parent cells. OXGR1 was identified as a receptor for: a) α-ketoglutarate in 2004; b) three leukotrienes viz., leukotrienes E4, C4, and D4 in 2013. and c) itaconate in 2023. These ligands have the following relative potencies in stimulating responses in OXGR1-bearing cells (Note that LTE4 can stimulate OXGR1 at concentrations far lower than those of the other four ligands):
1993/3173) Education (Individual Pupils' Achievements) (Information) Regulations 1993 (S.I. 1993/3182) Education (European Economic Area) (Amendment) Regulations 1993 (S.I. 1993/3183) Education (European Economic Area) (Scotland) Regulations 1993 (S.I. 1993/3184) Liquor Licensing (Fees) (Scotland) Order 1993 (S.I. 1993/3185) Advice and Assistance (Assistance by Way of Representation) (Scotland) Amendment (No. 2) Regulations 1993 (S.I. 1993/3186) Advice and Assistance (Financial Limit) (Scotland) Regulations 1993 (S.I. 1993/3187) Education (Grant–maintained Schools) (Initial Sponsor Governors) Regulations 1993 (S.I. 1993/3188) Education (Acquisition of Grant-maintained Status) (Ballot Information) Regulations 1993 (S.I. 1993/3189) Supreme Court Fees (Amendment) Order 1993 (S.I. 1993/3191) Cod and Saithe (Specified Sea Areas) (Prohibition of Fishing) Order 1993 (S.I. 1993/3192) Haddock, Hake, Nephrops, Plaice and Sole (Specified Sea Areas) (Prohibition of Fishing) Order 1993 (S.I. 1993/3193) Social Security (Severe Disablement Allowance) Amendment Regulations 1993 (S.I. 1993/3194) Doncaster Borough Council (North Bridge Relief Road) (Crossing of Navigable Waterway (Sheffield and South Yorkshire Navigation River Don New Cut)) Scheme 1991 Confirmation Instrument 1993 (S.I. 1993/3195) Education (Distribution by Schools of Information about Further Education Institutions) (England) Regulations 1993 (S.I. 1993/3197) Nitrate Sensitive Areas (Designation) (Amendment) Order 1993 (S.I. 1993/3198) Broadcasting (Restrictions on the Holding of Licences) (Amendment) Order 1993 (S.I.
Sources: en.wikipedia.org
== Mechanism of action == Ionophores are chemical compounds that reversibly bind and transport ions through biological membranes in the absence of a protein pore. This can disrupt the membrane potential, and thus these substances could exhibit cytotoxic properties. Ionophores modify the permeability of biological membranes toward certain ions to which they show affinity and selectivity. Many ionophores are lipid-soluble and transport ions across hydrophobic membranes, such as lipid bilayers found in the living cells or synthetic vesicles (liposomes), or liquid polymeric membranes (carrier-based ion selective electrodes). Structurally, an ionophore contains a hydrophilic center and a hydrophobic portion that interacts with the membrane. Ions are bound to the hydrophilic center and form an ionophore-ion complex. The structure of the ionophore-ion complex has been verified by X-ray crystallography.
== Arab counter-proposal == On 21 February, the Arab leaders of Egypt, Jordan, Qatar, UAE, Saudi Arabia, Kuwait, and Bahrain met in Saudi Arabia to discuss the future of Gaza. Their goal was to be a "united front" and provide an alternative to Trump's plan. Ibrahim Dalalsha, director of a political research group in West Bank, said the process would be complex and that the greatest obstacle for the Arab leaders is to introduce a plan that is realistic and can be enforced on the Palestinian factions, while at the same time being a plan that the US and Israel could accept. Arab leaders planned to meet for a broader summit on 4 March in Cairo to find a plan for Gaza before their diplomats travel to Washington D.C. "within weeks" to meet with President Trump to present their counter plan.
== External links == WHO: China—World Health Organization Country Profile WHO: China Office—World Health Organization China Office (in Chinese) 乙肝·论坛·乙肝病毒携带者的网上家园-肝胆相照—"In the Hepatitis Camp" (in English) Hepatitis B Carriers BBS—"In the Hepatitis Camp"
== Function == This gene encodes MC3R, a G-protein coupled receptor (GPCR) for melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) that is expressed in the brain. Early research suggests that humans who carry loss-of-function mutations in MC3R may have a somewhat later onset of puberty (roughly 5 months later for heterozygous girls). This along with evidence from animal models has led some researchers to propose that MC3R may have a role in regulating the timing of sexual maturity.
Sources: en.wikipedia.org
Mass spectrometry provides the most direct confirmation of molecular mass. Reversed-phase chromatography adds a retention-time signature that supports identity when compared against a reference standard. No single method is sufficient on its own.
Cool, dry conditions with desiccant are standard for the solid form. Long-term storage is usually at freezer temperatures, with short-term handling at refrigerator temperature. Vials are allowed to equilibrate before opening to prevent condensation.
Lipid conjugation increases hydrophobicity, which shifts chromatographic retention and can broaden peaks. It also creates additional related species when acylation is incomplete or the chain is oxidised. Methods are therefore developed to separate acylated and non-acylated forms explicitly.
It is a synthetic peptide triagonist that engages GIP, GLP-1, and glucagon receptors. Investigational compounds in this class are studied for metabolic conditions rather than for a single organ system.